|
C20ORF24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.259200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.019500E-03 |
| Normal-vs-Stage2 |
2.726400E-01 |
| Normal-vs-Stage3 |
9.456400E-01 |
| Normal-vs-Stage4 |
5.218300E-03 |
| Stage1-vs-Stage2 |
3.249200E-01 |
| Stage1-vs-Stage3 |
7.720900E-03 |
| Stage1-vs-Stage4 |
1.95940999999644E-05 |
| Stage2-vs-Stage3 |
3.480600E-01 |
| Stage2-vs-Stage4 |
1.701160E-03 |
| Stage3-vs-Stage4 |
1.091810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.242600E-01 |
| Normal-vs-AfricanAmerican |
7.284800E-01 |
| Normal-vs-Asian |
7.967800E-01 |
| Caucasian-vs-AfricanAmerican |
8.698800E-01 |
| Caucasian-vs-Asian |
9.922000E-01 |
| AfricanAmerican-vs-Asian |
9.396800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.440000E-01 |
| Normal-vs-Female |
2.047000E-01 |
| Male-vs-Female |
4.906400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.969800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.451850E-01 |
| Normal-vs-Age(61-80Yrs) |
5.776800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.696000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.409600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.267800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.208000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.320800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.165200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.606000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.32949999999787E-05 |
| Normal-vs-Grade 2 |
8.06360000000783E-05 |
| Normal-vs-Grade 3 |
9.486400E-01 |
| Normal-vs-Grade 4 |
3.036900E-04 |
| Grade 1-vs-Grade 2 |
3.271900E-02 |
| Grade 1-vs-Grade 3 |
2.033200E-04 |
| Grade 1-vs-Grade 4 |
1.55210000407635E-08 |
| Grade 2-vs-Grade 3 |
8.993200E-04 |
| Grade 2-vs-Grade 4 |
3.81529999815555E-08 |
| Grade 3-vs-Grade 4 |
1.382030E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.18214335490075E-12 |
| Normal-vs-ccB subtype |
2.248000E-02 |
| ccA subtype-vs-ccB subtype |
4.14113188185183E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.981400E-01 |
| Normal-vs-N1 |
2.851700E-02 |
| N0-vs-N1 |
1.691810E-02 |
|
|
